Müllerian Inhibiting Substance Inhibits Testosterone Synthesis in Adult Rats

Abstract

Müllerian inhibiting substance (MIS) is a gonadal hormone that causes regression of the Müllerian ducts during male sexual differentiation. Postnatally, MIS inhibits the proliferation and differentiation of immature Leydig cells, and transgenic mice that over‐express MIS have decreased serum testosterone concentrations. To elucidate the effects of MIS on androgen regulation in the postnatal testis, we examined testosterone synthesis in adult Sprague‐Dawley rats following intratesticular and intraperitoneal injections of MIS. Intratesticular MIS injection achieved high local concentrations of MIS (574.0 ± 60.0 ng/mL) at 4 hours, with a corresponding decline in serum testosterone concentrations to 0.7 ± 0.1 ng/mL, compared to 1.1 ± 0.2 ng/mL with intraperitoneal MIS and 1.6 ± 0.1 ng/mL with intratesticular vehicle (IT‐Veh) (P < .001). Intratesticular administration of MIS (IT‐MIS) resulted in much higher serum and testicular interstitial fluid MIS concentrations than the intraperitoneal route. To directly examine the testosterone production rate in MIS‐treated animals, we isolated Leydig cells from MIS and vehicle‐injected testes. Primary Leydig cells exposed to MIS had a lower testosterone production rate and decreased expression of p450c17 (hydroxylase/lyase) and luteinizing hormone (LH) receptor mRNAs than that of vehicle‐injected controls or the noninjected contralateral testis. In conclusion, intratesticular administration of MIS caused a decline in serum testosterone concentrations by decreasing the rate of testosterone biosynthesis, confirming that MIS can regulate adult Leydig cell androgen production. The ability of MIS to down‐regulate mRNA expression of the p450c17 and LH receptor genes suggests that this effect is mediated transcriptionally. These data indicate that, in addition to its role in embryonic differentiation of the male reproductive tract, MIS has a regulatory function in the postnatal testis. We conclude that one such function is for MIS to directly inhibit adult Leydig cell steroidogenesis.

The relation between Anti Mullerian hormone and hormone receptor status of breast cancer: a cross-sectional study

“…(18) In addition, AMH can influence steroid synthesis by altering hormone receptor expression. According to several studies, AMH can reduce expression of LH receptor (LHR) mRNA (19)(20)(21) or blunt an LH-mediated increase in LHR expression. (22) A study conducted by Ge and colleagues revealed that the risk of ER+, PR+, and ER+/PR+ breast cancer increases with higher levels of AMH.…”

Gene-Based Therapy: A New Approach to Feline Induced Sterilization?

“…Indirectly, AMH also determines the estrous cycle exhibition by controlling follicular development and maturation. Also, it has been shown that high concentrations of AMH in adult male rats inhibit adult Leydig cell steroidogenesis, thereby decreasing the testosterone secretion by Leydig cells [59]. Evidence collected from AMH research led to the hypothesis that a vectored-gene delivery approach might also successfully induce long-term infertility in males.…”

Effect of cadmium on the regulatory mechanism of steroidogenic pathway of Leydig cells during spermatogenesis

“…Staining of immature and adult Leydig cells with 3hydroxysteroid dehydrogenase-1 (3-HSD-1) and 11-HSD-1 biomarkers on post-treatment of EDS on 21st, 35th, and 56th day showed regeneration of Leydig cells with progenitor, immature and adult stage (Guo et al, 2013). There are some factors that affect the regeneration of Leydig cells, including anti-mullerian hormone (AMH), non-leydig testicular cell factor, and gonadotropin-secreted LH (O'Shaughnessy, Morris, & Baker, 2008;Sriraman et al, 2001). The follicle-stimulating hormone (FSH) released from the gonadotrophic has a positive and negative feedback mechanism to control the secretion of AMH and DHH secretion binding the follicle-stimulating hormone receptor (FSHR) on the Sertoli cells of the testes (Blagosklonova, 2002;Kim & Griswold, 2001).…”